|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
CTG007813112 |
003 |
DE-627 |
005 |
20230425171259.0 |
007 |
cr uuu---uuuuu |
008 |
210818s2022 xx |||||o 00| ||ita c |
035 |
|
|
|a (DE-627)CTG007813112
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2015-003341-25-IT
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)IPP-201101/005
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)2015-003341-25-HU
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a ita
|
245 |
1 |
0 |
|a Uno studio per valutare l'efficacia e la sicurezza del farmaco in studio, quando ai pazienti ¿ dato un dosaggio di 200 mcg di IPP-201101 pi¿ standard di cura, in pazienti con lupus eritematoso sistemico.
|b A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus - A study to evaluate the effectiveness and safety of the study drug for patients with SLE.
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 19-01-2021, Last updated: 2022-11-24
|
650 |
|
4 |
|a Medical Condition: Systemic Lupus Erythematosus MedDRA version: 21.1Level: PTClassification code 10042945Term: Systemic lupus erythematosusSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Body processes [G] - Immune system processes [G12]
|
650 |
|
4 |
|a Study Type: Interventional
|
650 |
|
4 |
|a Phase: Phase 3
|
650 |
|
4 |
|a Recruitment Status: Not yet recruiting
|
650 |
|
4 |
|a 610
|
773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2022) vom: 14. März
|
773 |
1 |
8 |
|g year:2022
|g day:14
|g month:03
|
856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003341-25
|z kostenfrei
|3 Volltext
|
912 |
|
|
|a GBV_CTG
|
912 |
|
|
|a SSG-OLC-PHA
|
951 |
|
|
|a AR
|
952 |
|
|
|j 2022
|b 14
|c 03
|